Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05553119 · ClinicalTrials.gov registry record
A Study of Home-based Pulmonary Rehabilitation and Health Coaching to Treat Bronchiectasis
A clinical trial of Bronchiectasis, sponsored by Mayo Clinic.
- Completed
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT05553119: Completed study of Bronchiectasis, sponsored by Mayo Clinic.
NCT05553119 is a study of Bronchiectasis that has completed, run by Mayo Clinic. The registered enrollment target is 35 participants, below the 385-participant average among 13 other Bronchiectasis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05553119, a study of Bronchiectasis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to gather information on the effectiveness on a home-based pulmonary rehabilitation in patients with bronchiectasis.
Primary Outcome
As defined by the COPD Assessment Test (CAT). The CAT is a validated tool for measuring health status in patients with bronchiectasis and is divided into eight domains of cough, mucous production, chest tightness, shortness of breath with activity, activity limitation at home, confidence leaving home, sleep quality, and energy. A lower score suggests no health-related quality of life (HRQL) impairment, while the maximum score of 40 represents significant impact.
Conditions Studied
Interventions
- BEHAVIORAL Home Rehabilitation Monitoring System
- BEHAVIORAL Health coaching calls
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2022-08-25 |
| Est. Completion | 2023-07-30 |
What the finished NCT05553119 record still lists
NCT05553119 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 385-participant average among 13 other Bronchiectasis trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Bronchiectasis appearing as the primary indexed condition, and to 2 interventions - of which Home Rehabilitation Monitoring System is the first listed.
NCT05553119 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05553119 about?
NCT05553119 is a clinical study titled "A Study of Home-based Pulmonary Rehabilitation and Health Coaching to Treat Bronchiectasis". The purpose of this study is to gather information on the effectiveness on a home-based pulmonary rehabilitation in patients with bronchiectasis.
What is the current status of trial NCT05553119?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2022-08-25. Estimated completion is 2023-07-30.
What conditions does trial NCT05553119 study?
This clinical trial studies the following conditions: Bronchiectasis.
What interventions are being tested in trial NCT05553119?
The interventions under investigation include: Home Rehabilitation Monitoring System (BEHAVIORAL), Health coaching calls (BEHAVIORAL).
Who is sponsoring clinical trial NCT05553119?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05553119 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchiectasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05553119's enrollment target sits among peer trials
35 8th of 13 higher than 6 of 13 other Bronchiectasis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bronchiectasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
RECRUITING · Phase 3
-
Evaluation Of The Lung Microbiome In NTM Bronchiectasis
RECRUITING
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
-
Itraconazole Therapy In Bronchiectasis With Airway Mold
RECRUITING · Phase 4
-
OLE Therapy With BE Patients in Home Care Study
RECRUITING · NA
-
Natural History of Bronchiectasis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI